Print

Other Publications

  1. Ali M, Bath P, Brady M, Davis S, Diener H-C, Donnan G, Fisher M, Hacke W, Hanley DF, Luby M, Tsivgoulis G, Wahlgren N, Warach S, Lees KR, on behalf of the VISTA Steering Committees, Development, Expansion and Use of a Stroke Clinical Trials Resource for Novel Exploratory Analyses, International Journal of Stroke 2012;7: 133-138.

 

Abstracts

  1. Dowlatshahi D, Demchuk AM, Flaherty ML, Ali M, Lyden P and Smith EE, and the VISTA Collaborators. A Clinically Relevant Definition for Hematoma Growth Following Intracerebral Hemorrhage. Abstract Presented at ESC, Sweden, 2009.
  2. Dowlatshahi D, Smith EE, Flaherty ML, Ali M, Lyden P and Demchuk AM, and the VISTA Collaborators. Small intracerebral hemorrhages are associated with a low rate of hematoma expansion and do not seem appropriate for ICH hemostatic treatment trials. Abstract Presented at ESC, Sweden, 2009.
  3. Dowlatshahi D, Demchuk AM, Flaherty ML, Ali M, Lyden P and Smith EE, and the VISTA Collaborators. A Clinically Relevant Definition for Hematoma Growth Following Intracerebral Hemorrhage. Abstract Presented at CFNS, Nova Scotia, 2009.
  4. Dowlatshahi D, Smith EE, Flaherty ML, Ali M, Lyden P and Demchuk AM, and the VISTA Collaborators. Small intracerebral hemorrhages are associated with a low rate of hematoma expansion and do not seem appropriate for ICH hemostatic treatment trials. Abstract Presented at CFNS, Nova Scotia, 2009.
  5. Rincon F, Lyden P, Mayer S, on behalf of VISTA-ICH Investigators. Association between hyperthermia, functional outcome, and hematoma growth after ICH, Abstract Presented at ESC, Hamburg, Germany, 2011.
  6. Ali M, Lyden P, Sacco RL, Shuaib A, Lees KR, for the VISTA investigators. Natural History of Complications after Intracerebral Haemorrhage. Posterat AAN meeting, Seattle, USA, 2009.
  7. Florczak-Rzepka M, Steiner T, on behalf of the VISTA-ICH Collaboration. Biomarkers associated with 90-day mortality in patients with intracerebral haemorrhage (ICH). E-Poster presentation, European Stroke Conference, London 2013.
  8. Florczak-Rzepka M, Steiner T, on behalf of the VISTA-ICH Collaboration. Glial Fibrillary Acidic Protein (GFAP) in intracerebral haemorrhage (ICH): friend or foe? Platform presentation at European Stroke Conference, London 2013.
  9. Ali M, Hazelton C, Brady M, Lyden P, Pollock A, On Behalf of the VISTA Collaboration. Recovery from Post-Stroke Visual Impairment: Evidence from a Clinical Trials Resource. Presented at UKSF, 2011
  10. Ali M, Hazelton C, Brady M, Lyden P, Pollock A, On Behalf of the VISTA Collaboration. Recovery from Post-Stroke Visual Impairment: Evidence from a Clinical Trials Resource. Presented at International Stroke Conference 2012, New Orleans, USA
  11. Ali M, Hazelton C, Lyden P, Pollock, Brady M on behalf of the VISTA Collaboration. Recovery from Post-Stroke Visual Impairment: Evidence from the Virtual International Stroke Trials Archive (VISTA), Platform Presentation at European Stroke Conference 2012, Lisbon, Portugal
  12. Phan TG, Chen J, Srikanth V, Ma H, Clissold, Ly J, on behalf of the VISTA Collaboration. Prediction of disability outcome following ICH: a decision tree analysis from VISTA collaboration. Poster presented at ESC 2013, London, UK.
  13. Lee RJ, Frantzias J, Lyden PD, and Al-Shahi Salman R for the ICH growth IPDMA collaborators and the VISTA-ICH Collaboration. The risk of intracerebral haemorrhage (ICH) growth by time of diagnostic scan after ICH symptom onset: individual patient data meta-analysis (IPDMA). Platform presentation at the UK Stroke Forum 2014, Harrogate, UK.
  14. Wu T, Campbell B, Strbian D, Yassi N, Putaala J, Tatlisumak T, Davis S, Meretoja A on behalf of the Helsinki ICH Study and the VISTA-ICH Collaboration. Impact of Pre-stroke Sulphonylurea and Metformin Use on Outcome of Intracerebral Hemorrhage. Poster presented at ISC 2015.
  15. Wolz R, Royle N, Gray K, Xie Z, Tuthill T on behalf of the VISTA-ICH investigators, Prediction of Hemorrhagic Growth using Textural Pattern Analysis, Poster Presented at ISC 2016, Los Angeles, USA. 
  16. Zandieh A, Messé SR, Cucchiara B, Mullen MT, Kasner SE, on behalf of the VISTA-ICH Collaborators, Prophylactic Anti-Epileptic Drugs and Spontaneous Intracerebral Hemorrhage, Poster Presented at ISC 2016, Los Angeles, USA
  17. Sivakumar S, Georgiadis AL, Majidi S, Shah Miran M, Steiner T, Qureshi AI on behalf of the VISTA-ICH Collaboration. Effect of cigarette smoking on hematoma expansion and 3-month outcomes patients with intracerebral hemorrhage. Poster Presentation at the ESOC, Barcelona, Spain, 2016.
  18. Schoemaker R, Nayak S, Denny WS, Jonsson N, Karlsson MO, Harnisch LO, on behalf of the VISTA-ICH Collaborators. Modelling and simulation of neurological endpoints (modified Rankin Scale [mRS] and National Institutes of Health Stroke Scale [NIHSS]) to aid clinical trial design in intracerebral haemorrhage. Platform Presentation at Population Approach Group Europe (PAGE), Lisboa, Portugal, 2016
  19. Ziai et al, Evaluation of Sex, Racial and Geographic Demographics and Outcomes in Clinical Trials of Spontaneous Intracerebral Hemorrhage, ISC 2017, Houseton, Tx, USA, Platform Presentation
  20. Ziai et al, Hematoma Retraction In Spontaneous Intracerebral Hemorrhage: Frequency, Functional Significance And Relation To Perihematomal Edema, ISC 2017, Houseton, Tx, USA, Moderated Poster Presentation
  21. Yogendrakumar V, Smith EE, Demchuk AM, Aviv RI, Rodriguez-Luna D, Molina CA, Blas YS, Dzialowski I, Kobayashi A, Boulanger JM, Lum C, Gubitz G, Padma V, Roy J, Kase CS, Bhatia R, Ali M, Lyden P, Hill MD, and Dowlatshahi D, On behalf of the PREDICT/Sunnybrook ICH CTA Study Group and the VISTA Collaboration. What Definition of Early Neurological Worsening Predicts Poor Outcome in Acute Intracerebral Hemorrhage? ISC 2017, Houseton, Tx, USA, Poster Presentation 

All chairs